Standout Papers
Citation Impact
Citing Papers
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Breast cancer
2019 Standout
Mechanism of Release and Fate of Excised Oligonucleotides during Nucleotide Excision Repair
2012 StandoutNobel
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Clinical management of BRCA1 and BRCA2 mutation carriers
2006
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
2011
BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage
2011
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland
2005
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
2006
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers
2015
Pregnancy and the risk of breast cancer
2007
How were new medicines discovered?
2011 Standout
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Impact of high-throughput screening in biomedical research
2011 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
2015
Photopolymerization in 3D Printing
2019 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Ovarian Cancer Prevention in High-risk Women
2017
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer
2009
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Classification and Grading of Canine Mammary Tumors
2011 Standout
Spontaneous Mammary Intraepithelial Lesions in Dogs—A Model of Breast Cancer
2007
Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk Reduction
2007
Environmental Exposures and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations
2011
Works of Tim Rebbeck being referenced
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout